Novo Nordisk to Invest $78M in Iran Plant

Sep 22, 2015

Reuters

Novo Nordisk will invest $78 million to build a manufacturing plant in Iran, according to a Reuters article. The company has had a subsidiary in the country since 2005 selling insulin and employing 130 people.

"We have been working on this for a long time, also before the nuclear agreement was settled, and we have confidence that the Iranian society and economy is developing positively," Ole Moelskov Bech, head of the firm's Near East unit, told Reuters.

Read the full Reuters story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments